Filing Details
- Accession Number:
- 0001415889-13-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-07 12:23:29
- Reporting Period:
- 2012-12-28
- Filing Date:
- 2013-01-07
- Filing Date Changed:
- 2013-01-07
- Accepted Time:
- 2013-01-07 12:23:29
- Original Submission Date:
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1374328 | Bond Laboratories, Inc. | BNLB.OB | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247604 | T Jason Adelman | Cipher Capital Partners C/o Rothschild 1251 Avenue Of The Americas, Suite 936 New York NY 10020 |
No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings |
|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-28 | 4,202,260 | $0.00 | 12,971,808 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date |
|---|---|---|---|
| Common Stock | Warrant | $0.30 | 2012-11-15 |
| Common Stock | Series C Convertible Preferred Stock | $0.00 | 2012-11-15 |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2015-11-15 | 667,083 | 667,083 | Direct |
| 1,334,000 | 1,334,000 | Direct |
Footnotes
- The Reporting Person acquired the shares of Issuer's common stock ("Common Stock") for aggregate consideration of $50,000 in a privately negotiated transaction.
- The Warrant contains a provision preventing the exercise of the Warrant if, as a result of such exercise, the Reporting Person would beneficially own, together with all other shares of Common Stock beneficially owned by the Reporting Person, in excess of 9.99% of the Issuer's Common Stock issued and outstanding.
- Each share of Series C Convertible Preferred Stock ("Series C Preferred") is convertible into 40,000 shares of Common Stock.
- The Series C Preferred is perpetual.
- The Certificate of Designations, Preferences and Rights of the Series C Preferred contains a provision preventing the conversion of the Series C Preferred if, as a result of such conversion, the Reporting Person would beneficially own, together with all other shares of Common Stock beneficially owned by the Reporting Person, in excess of 4.99% of the Issuer's Common Stock issued and outstanding.
Insider Monkey Small Cap Strategy
Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!
